{"id":683,"date":"2023-03-01T10:57:53","date_gmt":"2023-03-01T10:57:53","guid":{"rendered":"https:\/\/www.ide-cso.com\/en\/?post_type=portfolio&#038;p=683"},"modified":"2023-05-27T08:07:04","modified_gmt":"2023-05-27T08:07:04","slug":"organization-of-clinical-trials-ba-be-and-phase-1","status":"publish","type":"portfolio","link":"https:\/\/www.ide-cso.com\/en\/services\/organization-of-clinical-trials-ba-be-and-phase-1\/","title":{"rendered":"Organization of Clinical Trials (BA\/BE and Phase 1)"},"content":{"rendered":"<p>[vc_row el_id=&#8221;by-be-calismalari&#8221; css=&#8221;.vc_custom_1672989270027{padding-top: 35px !important;}&#8221;][vc_column][vc_custom_heading text=&#8221;Organization of Clinical Trials (BA\/BE and Phase 1)&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;]<div class=\"porto-animation  margin-auto\" data-appear-animation=\"fadeInLeftBig\" data-appear-animation-delay=\"200\">[vc_separator color=&#8221;custom&#8221; align=&#8221;align_left&#8221; border_width=&#8221;3&#8243; el_width=&#8221;10&#8243; style=&#8221;solid&#8221; accent_color=&#8221;#00acb7&#8243; css=&#8221;.vc_custom_1672992122979{margin-top: -10px !important;}&#8221;]<\/div>[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n<ul>\n<li>BA\/BE Study Design, Execution and Consultancy<\/li>\n<li>BA\/BE Pivotal\/Pilot Studies<\/li>\n<li>Preparation and Submittion of Ethics Committee and Ministry Application Dossiers<\/li>\n<li>Selection of Clinical and Bioanalytical Centers<\/li>\n<li>Clinical Monitoring<\/li>\n<li>Organizion of Bioanalytical and Clinical Studies<\/li>\n<li>Preparation of Statistical Reports and ICH E3-compliant Study Reports<\/li>\n<li>Providing BA\/BE Scientific Reporting Support to innovator companies<\/li>\n<li>Organization of dissolution studies<\/li>\n<li>In Vitro-In Vivo Correlation (IVIVC) evaluations<\/li>\n<li>Biosimilar clinical studies<\/li>\n<li>Medical device clinical studies<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row el_id=&#8221;by-be-calismalari&#8221; css=&#8221;.vc_custom_1672989270027{padding-top: 35px !important;}&#8221;][vc_column][vc_custom_heading text=&#8221;Organization of Clinical Trials (BA\/BE and Phase 1)&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] BA\/BE Study Design, Execution and Consultancy BA\/BE Pivotal\/Pilot Studies Preparation and Submittion of Ethics Committee and Ministry Application Dossiers Selection of Clinical and Bioanalytical Centers Clinical Monitoring Organizion of Bioanalytical and Clinical Studies Preparation of Statistical Reports and ICH E3-compliant [&hellip;]<\/p>\n","protected":false},"featured_media":623,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"portfolio_cat":[19],"portfolio_skills":[],"class_list":["post-683","portfolio","type-portfolio","status-publish","has-post-thumbnail","hentry","portfolio_cat-by-be-calismalari-ve-klinik-arastirma-organizasyonu"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Organization of Clinical Trials (BA\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Organization of Clinical Trials (BA\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma\" \/>\n<meta property=\"og:description\" content=\"[vc_row el_id=&#8221;by-be-calismalari&#8221; css=&#8221;.vc_custom_1672989270027{padding-top: 35px !important;}&#8221;][vc_column][vc_custom_heading text=&#8221;Organization of Clinical Trials (BA\/BE and Phase 1)&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] BA\/BE Study Design, Execution and Consultancy BA\/BE Pivotal\/Pilot Studies Preparation and Submittion of Ethics Committee and Ministry Application Dossiers Selection of Clinical and Bioanalytical Centers Clinical Monitoring Organizion of Bioanalytical and Clinical Studies Preparation of Statistical Reports and ICH E3-compliant [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/\" \/>\n<meta property=\"og:site_name\" content=\"\u0130de \u0130la\u00e7 Ruhsatland\u0131rma\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-27T08:07:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ide-cso.com\/en\/wp-content\/uploads\/2023\/01\/by-be.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/\",\"url\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/\",\"name\":\"Organization of Clinical Trials (BA\\\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/by-be.jpg\",\"datePublished\":\"2023-03-01T10:57:53+00:00\",\"dateModified\":\"2023-05-27T08:07:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/by-be.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/by-be.jpg\",\"width\":500,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetler\\\/organization-of-clinical-trials-ba-be-and-phase-1\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hizmetlerimiz\",\"item\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/hizmetlerimiz\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Organization of Clinical Trials (BA\\\/BE and Phase 1)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/\",\"name\":\"\u0130de \u0130la\u00e7 Ruhsatland\u0131rma\",\"description\":\"Biyofarmas\u00f6tik Dan\u0131\u015fmanl\u0131k ve E\u011fitim\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ide-cso.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Organization of Clinical Trials (BA\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/","og_locale":"tr_TR","og_type":"article","og_title":"Organization of Clinical Trials (BA\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma","og_description":"[vc_row el_id=&#8221;by-be-calismalari&#8221; css=&#8221;.vc_custom_1672989270027{padding-top: 35px !important;}&#8221;][vc_column][vc_custom_heading text=&#8221;Organization of Clinical Trials (BA\/BE and Phase 1)&#8221; font_container=&#8221;tag:h3|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text] BA\/BE Study Design, Execution and Consultancy BA\/BE Pivotal\/Pilot Studies Preparation and Submittion of Ethics Committee and Ministry Application Dossiers Selection of Clinical and Bioanalytical Centers Clinical Monitoring Organizion of Bioanalytical and Clinical Studies Preparation of Statistical Reports and ICH E3-compliant [&hellip;]","og_url":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/","og_site_name":"\u0130de \u0130la\u00e7 Ruhsatland\u0131rma","article_modified_time":"2023-05-27T08:07:04+00:00","og_image":[{"width":500,"height":500,"url":"https:\/\/www.ide-cso.com\/en\/wp-content\/uploads\/2023\/01\/by-be.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tahmini okuma s\u00fcresi":"1 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/","url":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/","name":"Organization of Clinical Trials (BA\/BE and Phase 1) - \u0130de \u0130la\u00e7 Ruhsatland\u0131rma","isPartOf":{"@id":"https:\/\/www.ide-cso.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/#primaryimage"},"image":{"@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ide-cso.com\/en\/wp-content\/uploads\/2023\/01\/by-be.jpg","datePublished":"2023-03-01T10:57:53+00:00","dateModified":"2023-05-27T08:07:04+00:00","breadcrumb":{"@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/#primaryimage","url":"https:\/\/www.ide-cso.com\/en\/wp-content\/uploads\/2023\/01\/by-be.jpg","contentUrl":"https:\/\/www.ide-cso.com\/en\/wp-content\/uploads\/2023\/01\/by-be.jpg","width":500,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.ide-cso.com\/en\/hizmetler\/organization-of-clinical-trials-ba-be-and-phase-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/www.ide-cso.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hizmetlerimiz","item":"https:\/\/www.ide-cso.com\/en\/hizmetlerimiz\/"},{"@type":"ListItem","position":3,"name":"Organization of Clinical Trials (BA\/BE and Phase 1)"}]},{"@type":"WebSite","@id":"https:\/\/www.ide-cso.com\/en\/#website","url":"https:\/\/www.ide-cso.com\/en\/","name":"\u0130de \u0130la\u00e7 Ruhsatland\u0131rma","description":"Biyofarmas\u00f6tik Dan\u0131\u015fmanl\u0131k ve E\u011fitim","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ide-cso.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"}]}},"_links":{"self":[{"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio\/683","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio"}],"about":[{"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/types\/portfolio"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/comments?post=683"}],"version-history":[{"count":9,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio\/683\/revisions"}],"predecessor-version":[{"id":1331,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio\/683\/revisions\/1331"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/media\/623"}],"wp:attachment":[{"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/media?parent=683"}],"wp:term":[{"taxonomy":"portfolio_cat","embeddable":true,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio_cat?post=683"},{"taxonomy":"portfolio_skills","embeddable":true,"href":"https:\/\/www.ide-cso.com\/en\/wp-json\/wp\/v2\/portfolio_skills?post=683"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}